Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

被引：0
|
作者：
Johan Jendle
Jayne Smith-Palmer
Alexis Delbaere
Simona de Portu
Natalie Papo
William Valentine
Stéphane Roze
机构：
[1] Örebro University,
[2] Ossian Health Economics and Communications,undefined
[3] Medtronic International Trading Sarl,undefined
[4] HEVA HEOR,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Cost; Cost-effectiveness; Type 1 diabetes; Sensor-augmented pump therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1030
页数：15
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
    Jendle, Johan
    Smith-Palmer, Jayne
    Delbaere, Alexis
    de Portu, Simona
    Papo, Natalie
    Valentine, William
    Roze, Stephane
    DIABETES THERAPY, 2017, 8 (05) : 1015 - 1030
  • [2] A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes
    Ly, Trang T.
    Brnabic, Alan J. M.
    Eggleston, Andrew
    Kolivos, Athena
    McBride, Margaret E.
    Schrover, Rudolf
    Jones, Timothy W.
    VALUE IN HEALTH, 2014, 17 (05) : 561 - 569
  • [3] Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark
    Roze, S.
    de Portu, S.
    Smith-Palmer, J.
    Delbaere, A.
    Valentine, W.
    Ridderstrale, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 128 : 6 - 14
  • [4] Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey
    Roze, Stephane
    Smith-Palmer, Jayne
    de Portu, Simona
    Saltik, A. Zeynep Ozdemir
    Akgul, Tugba
    Deyneli, Oguzhan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (12) : 727 - 735
  • [5] Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type I diabetes in the Netherlands
    Roze, Stephane
    Smith-Palmer, Jayne
    de Portu, Simona
    Delbaere, Alexis
    de Brouwer, Bonnie
    de Valk, Harold W.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 73 - 82
  • [6] Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy
    Nicolucci, A.
    Rossi, M. C.
    D'Ostilio, D.
    Delbaere, A.
    de Portu, S.
    Roze, S.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (07) : 707 - 715
  • [7] New-generation diabetes management: glucose sensor-augmented insulin pump therapy
    Cengiz, Eda
    Sherr, Jennifer L.
    Weinzimer, Stuart A.
    Tamborlane, William V.
    EXPERT REVIEW OF MEDICAL DEVICES, 2011, 8 (04) : 449 - 458
  • [8] Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective
    Roze, Stephane
    Smith-Palmer, Jayne
    Valentine, William J.
    Cook, Mark
    Jethwa, Manisha
    de Portu, Simona
    Pickup, John C.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) : 236 - 242
  • [9] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [10] Living with Sensor-Augmented Pump Therapy in Type 1 Diabetes: Adolescents' and Parents' Search for Harmony
    Rashotte, Judy
    Tousignant, Kelley
    Richardson, Christine
    Fothergill-Bourbonnais, Frances
    Nakhla, Meranda M.
    Olivier, Patricia
    Lawson, Margaret L.
    CANADIAN JOURNAL OF DIABETES, 2014, 38 (04) : 256 - 262
12345